Author

Daniela Vilenski

Hebrew University of Jerusalem

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Systems Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Ariel M. Rubinstein· 1 shared Efrat Flashner-Abramson· 1 shared Heba Alkhatib· 1 shared Ibukun Adesoji Adejumobi· 1 shared Nataly Kravchenko‐BalashaiD· 1 shared Sangita Roy Chowdhury· 1 shared Shira Stefansky· 1 shared Swetha VasudevaniD· 1 shared

Activity by Year

2021-2021 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperSystems Biology

Ariel M. Rubinstein

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Overcoming Resistance to BRAFV600E Inhibition in Melanoma by Deciphering and Targeting Personalized Protein Network Alterations

Swetha Vasudevan, Efrat Flashner-Abramson, Heba Alkhatib, Sangita Roy Chowdhury, Ibukun Adesoji Adejumobi, Daniela Vilenski, Shira Stefansky, Ariel M. Rubinstein, Nataly Kravchenko‐Balasha

This study develops personalized drug combinations for BRAFV600E melanoma by analyzing patient-specific signaling networks, showing improved efficacy compared to standard therapies.

npj Precision Oncology · Jun 10, 2021Peer-reviewedSystems Biology